"10.1371_journal.pone.0072723","plos one","2014-01-09T00:00:00Z","Lisa J McGarry; Girishanthy Krishnarajah; Gregory Hill; Cristina Masseria; Michelle Skornicki; Narin Pruttivarasin; Bhakti Arondekar; Julie Roiz; Stephen I Pelton; Milton C Weinstein","OptumInsight, Cambridge, Massachusetts, United States of America; GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America; Boston University, Boston, Massachusetts, United States of America; Harvard University, Harvard School of Public Health, Boston, Massachusetts, United States of America","Conceived and designed the experiments: LJM GK GH CM SIP BA JR MCW CM BA. Performed the experiments: LJM GH MS NP CM. Analyzed the data: LJM GK GH CM MCW. Contributed reagents/materials/analysis tools: BA JR. Wrote the paper: LJM GH MS NP.","The authors have the following interests: GH, LJM, NP, MS, MCW (OptumInsight) received funding from GlaxoSmithKline Group of Companies to complete the disclosed research and to develop and publish this present manuscript. SIP and MCW have received consulting fees from GlaxoSmithKline Group of Companies. SIP has an advisory board membership with GlaxoSmithKline group of companies and Sanofi. BA, GK, JR and CM are existing or previous employees of GlaxoSmithKline Group of Companies. LJM, GH, MS, NP and MCW are employed by OptumInsight. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Lisa J McGarry","LJMG",10,TRUE,8,5,5,4,TRUE,TRUE,FALSE,0,NA,FALSE
